Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Free radicals in Parkinson's disease.

E Koutsilieri1, C Scheller, E Grünblatt

  • 1Clinical Neurochemistry and NPF Center of Excellence Research Laboratory, Department of Psychiatry and Psychotherapy, Julius-Maximilians-University, Fuechsleinstr. 15, 97080 Wuerzburg, Germany. eleni.koutsilieri@mail.uni-wuerzburg.de

Journal of Neurology
|October 11, 2002
PubMed
Summary

Oxidative stress (OS) is a key factor in Parkinson's disease (PD) development. Enhanced OS in PD patients and models, alongside antioxidant effectiveness, supports its central role in neurodegeneration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alterations in epigenetic marks and expression of genes related to stress regulation: an exploratory study among newborns after fetal repair of spina bifida aperta.

Epigenetics·2026
Same author

Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine ("Ecstasy") induced cytoskeletal damage.

Journal of neural transmission (Vienna, Austria : 1996)·2022
Same author

[Rare diagnosis of a bone-destructive lesion of the sphenoid sinus].

HNO·2020
Same author

[Hearing classification in patients with vestibular schwannoma using German-language test procedures].

HNO·2020
Same author

Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi.

AIDS research and therapy·2020
Same author

Psychiatric symptoms and expression of glucocorticoid receptor gene in cocaine users: A longitudinal study.

Journal of psychiatric research·2019

Area of Science:

  • Neuroscience
  • Pathobiochemistry
  • Oxidative Stress Research

Background:

  • Parkinson's disease (PD) pathogenesis involves multiple hypotheses, with oxidative stress (OS) gaining significant attention.
  • OS is implicated in normal aging processes and is demonstrably elevated in PD patients compared to healthy individuals.
  • Microglia activation, releasing free radicals and inflammatory cytokines, is observed in PD brains, contributing to neuroinflammation.

Purpose of the Study:

  • To consolidate evidence supporting the role of oxidative stress (OS) in the pathobiochemistry of Parkinson's disease (PD).
  • To highlight OS as an early feature of PD, preceding overt neurodegeneration.
  • To underscore the significance of OS in the cascade leading to dopaminergic neuron dysfunction and death.

Main Methods:

Related Experiment Videos

  • Review and synthesis of existing evidence on oxidative stress in Parkinson's disease.
  • Analysis of experimental models demonstrating OS-induced dopaminergic neurodegeneration.
  • Examination of biomarkers and pathological hallmarks associated with OS in PD.

Main Results:

  • Significant elevation of OS markers in Parkinson's disease patients compared to age-matched controls.
  • OS-dependent protein aggregation (advanced glycation end products) observed in early-stage PD (Lewy bodies).
  • Experimental models show that antioxidants can prevent toxin-induced dopaminergic neurodegeneration.

Conclusions:

  • A substantial body of evidence indicates that oxidative stress (OS) is a major contributor to Parkinson's disease pathobiochemistry.
  • OS plays a critical role in the synergistic cascade of toxicity, involving genetic predisposition and toxic events, leading to dopaminergic neuron death.
  • OS is significantly involved in generating cell death signals, including apoptosis, in the context of Parkinson's disease.